DAWN icon

Day One Biopharmaceuticals
DAWN

Overview Fund Activity

130 hedge funds and large institutions have $952M invested in Day One Biopharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 56 increasing their positions, 35 reducing their positions, and 21 closing their positions.

Holders
130
Holders Change
-9
Holders Change %
-6.47%
% of All Funds
2.07%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
56
Reduced
35
Closed
21
Calls
$813K
Puts
$775K
Net Calls
+$38K
Net Calls Change
-$391K

Top Buyers

1
BlackRock
1
BlackRock
New York
$57.5M
2
PHS
2
PFM Health Sciences
California
$27.3M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$6.68M
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$15.9M
5
B
5
Braidwell
Connecticut
$45.6M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$73.9M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$12.7M
3
Citadel Advisors
3
Citadel Advisors
Florida
$82.9K
4
Goldman Sachs
4
Goldman Sachs
New York
$20.2M
5
LGM
5
Logos Global Management
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
RCM
1
RA Capital Management
Massachusetts
$95.8M 7,809,852 – –
AVLSA
2
Atlas Venture Life Science Advisors
Massachusetts
$93.4M 7,608,394 – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$73.9M 6,026,128 -1,533,775 -20%
BlackRock
4
BlackRock
New York
$57.5M 4,688,434 +1,123,701 +32%
Vanguard Group
5
Vanguard Group
Pennsylvania
$56.8M 4,629,754 +346,090 +8%
Franklin Resources
6
Franklin Resources
California
$49.9M 4,067,332 +1,664 +0%
B
7
Braidwell
Connecticut
$45.6M 3,715,573 +353,760 +11%
State Street
8
State Street
Massachusetts
$36M 2,935,919 -418,407 -12%
Viking Global Investors
9
Viking Global Investors
Connecticut
$31.4M 2,558,563 – –
CPX
10
Canaan Partners XI
California
$30.6M 2,491,561 -56,842 -2%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$28.3M 2,308,028 -1,703 -0.1%
PHS
12
PFM Health Sciences
California
$27.3M 2,224,598 +1,077,458 +94%
NIP
13
Nicholas Investment Partners
California
$26.9M 2,188,654 -48,457 -2%
PCH
14
Polar Capital Holdings
United Kingdom
$23.7M 1,935,000 +160,385 +9%
Goldman Sachs
15
Goldman Sachs
New York
$20.2M 1,646,195 -746,328 -31%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$15.9M 1,293,114 +367,898 +40%
DM
17
Deerfield Management
New York
$15.6M 1,269,992 – –
BC
18
Boxer Capital
California
$14.6M 1,189,943 – –
TCM
19
TimesSquare Capital Management
New York
$14M 1,142,610 +336,910 +42%
Adage Capital Partners
20
Adage Capital Partners
Massachusetts
$12.7M 1,036,599 -1,405,901 -58%
BBA
21
Baker Bros. Advisors
New York
$12.3M 1,000,000 – –
Janus Henderson Group
22
Janus Henderson Group
United Kingdom
$10.1M 821,453 +133,943 +19%
CC
23
Commodore Capital
New York
$9.08M 739,661 – –
Pictet Asset Management
24
Pictet Asset Management
Switzerland
$7.36M 600,039 +600,039 New
DCM
25
DAFNA Capital Management
California
$7.2M 586,463 +79,363 +16%
1
2 3 4 5